Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Bausch Health Companies Inc.

https://www.bauschhealth.com/

Latest From Bausch Health Companies Inc.

Consumer Health Brands Will Be Included In Bausch's Spin-Out Of Bausch Part Of Company

“The spin-off will establish two separate companies, a fully integrated, pure play, eye health company built on the iconic Bausch Health brand and a long history of innovation, and an international diversified pharmaceutical company with leading physicians in gastroenterology, dermatology, aesthetics, neurology and an international pharma business,” says CEO Joseph Papa.

M & A OTC Drugs

Bausch To Spin-Out The Bausch Part Of Its Business

The company formerly known as Valeant, put together by a series of mergers, is ready to spin out the legacy Bausch + Lomb eyecare business that it used in its rebranding. 

Business Strategies Sales & Earnings

Keeping Track: Biogen’s Aducanumab Headlines Midsummer Submission Round-Up

The latest application submission news and highlights from the Pink Sheet’s US FDA Performance Tracker.

US FDA Performance Tracker Drug Review

Zydus Cadila Plans Indian Remdesivir Entry In July

Zydus Cadila hopes to launch its version of Gilead’s remdesivir by end-July in India, even as earlier licensees Hetero Drugs and Cipla have just commercialized the antiviral. Plans for pegylated interferon alfa-2b to treat COVID-19 include a trial in Mexico and an IND in the US. Separately, desidustat is being considered for additional indications.

Strategy Generic Drugs
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
  • Other Names / Subsidiaries
    • AB Sanitas
    • Afexa Life Sciences Inc.
    • Amoun Pharmaceutical
    • Aton Pharma, Inc.
    • Bausch Health Ireland Limited
    • Bausch + Lomb Holding International
    • Biovail Corporation
    • Callisto Pharmaceuticals, Inc. Dendreon Corporation
    • Dermik Laboratories, Inc.
    • Dow Pharmaceutical Sciences, Inc.
    • Eyetech Inc.
    • Graceway Pharmaceuticals, LLC
    • ICN Pharmaceuticals, Inc.
    • iNova Diagnostics, Inc.
    • Instituto Terapeutico Delta Ltda
    • Medicis Aesthetics Holdings Inc
    • Medicis Pharmaceutical Corporation
    • Mercury (Cayman) Holdings
    • OraPharma, Inc.
    • Ortho Dermatologics
    • Prestwick Pharmaceuticals, Inc.
    • PharmaSwiss S.A.
    • Pedinol Pharmacal, Inc.
    • Salix Pharmaceuticals Ltd. (InKine Pharmaceutical
    • Oceana Therapeutics, LLC
    • Q-Med Scandinavia, Inc.
    • Santarus, Inc.)
    • Sanitas AB
    • Solta Medical, Inc.
    • SPI Pharmaceuticals Inc
    • Synergetics USA, Inc.
    • Synergy Pharmaceuticals Inc.(SGYP)
    • Technolas Perfect Vision GmbH (TPV)
    • Ucyclyd Pharma, Inc.
    • Unilens Vision, Inc.
    • Viratek Pharma Inc
    • Valeant Pharmaceuticals International, Inc.
    • Xcel Pharmaceuticals, Inc.
UsernamePublicRestriction

Register